Tokyo, Japan

Bunzo Nomiya

This inventor holds 2 USPTO granted patents. Top assignees: Meiji Seika Co., Ltd., Meiji Seika Kaisha, Ltd.. Active years: 1976-1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bunzo Nomiya. Retrieved from https://idiyas.com/inventor/bunzo-nomiya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1976-1977

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Bunzo Nomiya

Introduction

Bunzo Nomiya is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antibiotic compositions. With a total of two patents to his name, Nomiya's work showcases his dedication to improving therapeutic options.

Latest Patents

Nomiya's latest patents include the "Antibiotic 9-acyl-3'-thiomethoxymethyl-SF-837 composition and process." This innovative derivative of the macrolide antibiotic SF-837 is produced by treating a 9,2'-diacyl- or 9-acyl-SF-837 composition with dimethylsulfoxide and acetic anhydride, followed by treatment with an alcohol or water-containing solvent. This novel compound not only exhibits high therapeutic effectiveness and low acute toxicity but also eliminates the bitter taste associated with its parent compounds, making it suitable for pediatric and veterinary use. Another significant patent is the "Composition for treating swine scour," which introduces novel alkyl 2,3,3-triiodoallyl ethers as disinfectants. These compounds are created through an addition reaction of alkyl-3-iodo-2-propinyl ethers with iodine, providing effective solutions for both poultry feed additives and swine scour treatment.

Career Highlights

Throughout his career, Bunzo Nomiya has worked with prominent companies such as Meiji Seika Co., Ltd. and Meiji Seika Kaisha, Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Nomiya has collaborated with esteemed colleagues, including Shigeharu Inouye and Shoji Omoto. These partnerships have fostered an environment of innovation and creativity, leading to the development of impactful inventions.

Conclusion

Bunzo Nomiya's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to advancing medical science. His work not only addresses critical health issues but also enhances the quality of life for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…